Dihydroquercetin (Taxifolin).

Taxifolin is dihydroquercetin, the direct precursor from which quercetin is formed in the plant flavonoid pathway, and the two differ only at the C2 to C3 bond. They share conjugation enzymes and much of their antioxidant behaviour.

Ascorbate reduces the flavonoid phenoxyl radical back to its active phenol, and flavonoids in turn spare ascorbate from oxidation. This mutual regeneration is the classic reason the two are formulated together.

Tocopherol stops lipid peroxidation chains in membranes and becomes a tocopheroxyl radical, which water phase phenolics such as taxifolin help return to the reduced form. The two phases cover each other.

Taxifolin is one of the monomeric flavonoids present in maritime pine bark extract alongside its procyanidins. An isolate on top of the extract raises the same molecule already there.

The standardised pine bark extract contains taxifolin as a characterised monomer within its procyanidin profile. Combining them stacks one flavonoid from two sources.

Grape seed proanthocyanidins are oligomers built from flavan-3-ol units closely related to taxifolin, and both act on endothelial nitric oxide signalling and capillary integrity. Their effects overlap rather than diverge.

Flavonoid radicals formed during antioxidant work are ultimately handled through the glutathione system, and flavonoids also raise Nrf2 driven glutathione synthesis enzymes. The two sit on the same redox chain.

Taxifolin carries the catechol arrangement that binds ferric iron, forming complexes that are poorly absorbed from the gut. Taken in the same sitting it lowers uptake from a non-heme iron supplement.

Catechol flavonoids bind copper as well as iron, forming complexes in the gut lumen that reduce free mineral available for uptake. The interaction is chemical rather than physiological.

Both are cleared largely by sulfotransferase and UDP-glucuronosyltransferase activity in gut wall and liver. Co-dosing puts them in competition at that step, which raises circulating levels of each.

Piperine slows intestinal glucuronidation and sulfation, the main route that clears flavonoids on first pass. Taxifolin exposure rises as a result.

When taxifolin donates a hydrogen atom from its catechol ring it becomes a semiquinone radical that has to be reduced back or conjugated. Glutathione is one of the reducing partners for that step, and N-acetylcysteine supplies the limiting cysteine for glutathione synthesis. The pairing is a biochemical rationale rather than a combination trial result.

Alpha-lipoic acid works in both aqueous and lipid environments and helps regenerate other reduced antioxidants, while taxifolin acts mainly as a chain-breaking hydrogen donor. Placing them together spreads coverage across compartments instead of duplicating one chemistry. No combination trial in people was retrieved for this pair.

Coenzyme Q10 sits inside membranes and mitochondrial inner leaflets; taxifolin partitions poorly into that space and acts more at the aqueous interface. The two therefore cover different sites rather than compete. This is a mechanistic pairing, not an outcome shown for the combination.

Astaxanthin sits across the phospholipid bilayer with its polar ends at both surfaces, which puts it where lipid peroxidation chains propagate. Taxifolin intercepts radicals before they reach that phase. The rationale is structural and the combination has not been tested together in people as far as the retrieved record shows.

The catechol B-ring of taxifolin binds divalent and trivalent metal ions, which is the same chemistry that makes flavonoid-rich foods lower mineral uptake from the same meal. Taking a mineral dose and a high flavonoid dose in the same swallow can therefore reduce how much of the mineral is taken up. Separating them by a couple of hours is the ordinary formulation answer.

Manganese is a divalent cation with no dedicated high-affinity intestinal carrier of its own, so it is sensitive to chelating dietary components. Catechol flavonoids including taxifolin can form complexes with it in the gut lumen. Direct measurement of this specific pair was not retrieved, so it is stated as chemistry.

Taxifolin has low aqueous solubility, and phospholipid dispersion is a standard way to keep a poorly soluble flavonoid in a finer, more wettable state through the gut. Lecithin supplies that phospholipid matrix. This describes a manufacturing approach, not a measured increase in blood levels for this molecule.

Phosphatidylcholine complexes hold a flavonoid at a lipid-water interface rather than as an undissolved crystal. That matters for taxifolin because dissolution, not permeability, is usually the slow step. Whether it changes circulating levels of taxifolin specifically was not established in the retrieved sources.

EGCG and taxifolin both donate hydrogen from phenolic rings and both undergo heavy phase II conjugation, so they overlap in mechanism but arrive with different timing and different microbial metabolites. Together they broaden the phenolic pool rather than raising one compound's exposure. Both also chelate minerals, so the same separate-from-minerals note applies.

Silymarin is built on a taxifolin core joined to a coniferyl alcohol unit, so the two molecules are chemically close relatives handled by the same glucuronidation and sulfation enzymes. Given together at high doses they can compete for that conjugation capacity, which changes exposure of both in ways that have not been measured directly. Flagging it as competition is more honest than calling it a boost.

Most of an oral taxifolin dose is not absorbed intact and reaches the colon, where bacteria cleave the ring system into smaller phenolic acids. A fermentable fibre shifts which organisms are doing that work. The direction of any change in the resulting metabolites is not established, so this is a modulating relationship rather than a benefit.

One animal report describes dietary dihydroquercetin acting alongside short-chain fatty acid signalling in intestinal tissue. Butyrate is the short-chain fatty acid most used as an ingredient in its own right. This is an animal-level mechanistic overlap and not human evidence for the pair.

Sulforaphane modifies Keap1 cysteines directly through its isothiocyanate group; catechol flavonoids reach the same pathway through oxidation products. The overlap is at the level of a transcriptional programme measured in cells, which is a marker of pathway activity and not an outcome in people.

Glutathione peroxidases are selenium-dependent enzymes that reduce hydroperoxides catalytically, while taxifolin quenches radicals stoichiometrically and is consumed doing it. Adequate selenium keeps the enzymatic arm running, so the two arms are complementary rather than redundant. No trial of the specific combination was retrieved.